EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Azathioprine Increases the Risk of Non‐Melanoma Skin Cancer Among Organ Transplant Recipients; an Updated Systematic Review and Meta‐Analysis

Amir Mohammad Salehi iD, Romina Rezaei iD, Alireza Sadeghi iD, Sanaz Omidi iD, Salman Khazaei iD, Bahareh Ebrahimi iD

Cancer Reports · 2026

DOI: 10.1002/cnr2.70473 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Cancer Reports, 2026. Verfasst von Amir Mohammad Salehi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Fetal and Pediatric Cardiovascular Research Center, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Azathioprine, Immunosuppressive Agents, Organ Transplantation, Non-Melanoma Skin Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vice Chancellor for Research and Technology, Hamadan University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Azathioprine (AZA) is a purine antimetabolite immunosuppressant that prevents the body from rejecting transplanted organs and is used in organ transplant recipients (OTRs). This study aimed to conduct a meta‐analysis to determine whether AZA usage has an increased risk of skin cancer in OTRs.

Methods

To explore the association between AZA usage and skin cancer through observational studies we conducted a systematic search across PubMed, Scopus, and Web of Science databases. A random effects model, subgroup analysis, and heterogeneity assessment were used for meta‐analysis. The quality of the included studies was assessed using the Newcastle Ottawa scale checklist.

Results

A total of 27 studies with 21 405 patients were included to the quantitative analysis. the overall summary estimate for non‐melanoma skin cancer (NMSC) risk in relation to AZA treatment according Odds ratio (OR) estimates, relative risk (RR) estimates and hazard ratio (HR) estimates were 1.83 (95% confidence interval (CI): 1.22, 2.75), 2.09 (CI: 1.41, 3.10), and 1.12 (CI: 0.93, 1.34), respectively. There was a substantial heterogeneity between studies in all types of OR estimates (I2 = 80.75%), RR estimates (I2 = 65.58%) and HR estimates (I2 = 54.63%). In the subgroup analysis, there was a significant increase in squamous cell carcinoma (SCC) risk in all three estimate effects while regarding basal cell carcinoma (BCC) none of them were significant.

Conclusion

Our findings indicate that OTRs treated with AZA are at an increased risk for SCC and NMSC. Therefore, it is recommended to prioritize monitoring for skin cancer in OTRs treated with AZA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AzathioprineImmunosuppressive AgentsOrgan TransplantationNon-Melanoma Skin NeoplasmsTransplant RecipientsSkin NeoplasmsHumansRisk FactorsCutaneous Squamous Cell CarcinomaCarcinoma, Squamous Cell

Stichwörter der Autor:innen

azathioprineorgan transplantskin cancersquamous cell carcinoma

Substanzen

AzathioprineImmunosuppressive Agents

Autor:innen und Institutionen

  • Fetal and Pediatric Cardiovascular Research Center, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Department of Epidemiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Department of Dermatology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.

ORCID-Profile: Amir Mohammad Salehi, Romina Rezaei, Alireza Sadeghi, Sanaz Omidi, Salman Khazaei, Bahareh Ebrahimi

Förderung

  • Vice Chancellor for Research and Technology, Hamadan University of Medical Sciences

Zitieren

APA

Salehi, A. M., Rezaei, R., Sadeghi, A., Omidi, S., Khazaei, S., & Ebrahimi, B. (2026). Azathioprine Increases the Risk of Non‐Melanoma Skin Cancer Among Organ Transplant Recipients; an Updated Systematic Review and Meta‐Analysis. Cancer Reports. https://doi.org/10.1002/cnr2.70473

Vancouver

Salehi AM, Rezaei R, Sadeghi A, Omidi S, Khazaei S, Ebrahimi B. Azathioprine Increases the Risk of Non‐Melanoma Skin Cancer Among Organ Transplant Recipients; an Updated Systematic Review and Meta‐Analysis. Cancer Reports. 2026. doi:10.1002/cnr2.70473

BibTeX
@article{Salehi2026,
  author = {Salehi, Amir Mohammad and Rezaei, Romina and Sadeghi, Alireza and Omidi, Sanaz and Khazaei, Salman and Ebrahimi, Bahareh},
  title = {Azathioprine Increases the Risk of Non‐Melanoma Skin Cancer Among Organ Transplant Recipients; an Updated Systematic Review and Meta‐Analysis},
  journal = {Cancer Reports},
  year = {2026},
  doi = {10.1002/cnr2.70473}
}
Kostenlos starten →